Ex-Aveo Exec's Penalty In SEC Deal Up To Magistrate Judge
By Christine Powell ( November 9, 2017, 7:38 PM EST) -- A Massachusetts magistrate judge will decide whether Aveo Pharmaceuticals Inc.'s former chief medical officer should pay a civil penalty under a deal that would resolve the U.S. Securities and Exchange Commission's allegations that he hid from investors the Food and Drug Administration's concerns about its flagship kidney cancer drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.